Navigation Links
Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
Date:2/14/2013

in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual results will be consistent with these forward-looking statements. For more information about the risks and uncertainties that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our annual report on Form 10-K and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law.

Contact:Joshua T. Brumm
Executive Vice President, Finance
Phone: 408-215-3311

Ramses Erdtmann
Vice President of Investor Relations
Phone: 408-215-3325Pharmacyclics, Inc.
Condensed Consolidated Balance Sheets
(unaudited; in thousands)

 December 31,June 30, 20122012AssetsCash, cash equivalents and marketable securities 1

$
317,114$
203,607Other current assets 2

29,3789,788Total current assets

346,492213,395Property and equipment, net

6,4033,842Other assets

2,2341,883Total assets

$
355,129$
219,120Liabilities and Stockholders' EquityDeferred revenue - current portion

$
8,139$
8,054Other current liabilities

21,11810,932Total current liabilities

29,25718,986Deferred revenue - non-current portion

62,56267,324Deferred rent

784687Total liabilities

92,60386,997Stockholders' equity

262,526132,123Total liabilities and stockholders' equity

$
355,129$
219,1201Marketable securities

$
9,681$
5,7112As of December 31, 2012 and June 30, 2012, Other current assets includes $26.6 million and $5.8 million, respectively, due to t
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
7. Pharmasset Reports Fiscal Year End 2011 Financial Results
8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent viruses ... is the Epstein Barr Virus (EBV), and one of these ... chronic inflammatory disease that destroys the body’s joints. As predicted ... high concentrations of EBV DNA in their bodies (1). ...
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of ... of tinnitus. Patients listen to sound therapy that is ... of weeks to months, their tinnitus volume decreases. , AudioNotch ... Music and Notched White Noise. Now, AudioNotch is pleased to ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 Date: ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, Warrington, ... only national nonprofit organization solely dedicated to finding a cure ... those affected worldwide, will host its annual Crystal Ball on ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... Jonathan Stamler Has Authored A New Understanding Of Heart ... Therapeutics,Inc. (OTC Bulletin Board: DSKA) ("Duska") announced today that ... exclusive scientific consultant,to advise on the clinical development of ... Dr. Stamler is the George Barth Geller Professor ...
... today,announced that healthcare industry veteran John J. Arlotta ... was announced during the,most recent NOVIS Board of ... http://www.newscom.com/cgi-bin/prnh/20081023/CLTH043LOGO ), "I am very ... and I look forward to,helping the company achieve ...
... Oct. 23 LI-COR(R) Biosciences in,partnership with ... system to LI-COR,s small animal imaging platforms. ... components required to connect,to the Pearl Imager(TM) ... veterinarians, is simple to operate, works safely ...
Cached Biology Technology:Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant 2Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant 3Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant 4Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant 5NOVIS Announces Appointment of John J. Arlotta as Chairman 2LI-COR Biosciences and Euthanex Corporation Provide Anesthesia System for Small Animal Imaging 2
(Date:4/17/2014)... serious conditions such as heart disease, epilepsy and pain, ... Unfortunately, there is still much scientists do not know ... unexpected insight into the structure of sodium channels and, ... which are responsible for ,fine-tuning, the activity of the ... edition of the Journal of Biological Chemistry . ...
(Date:4/17/2014)... expression is the process whereby the genetic information ... such as proteins, which have numerous different functions ... an important intermediary during gene expression, by relating ... mechanisms involved in manufacturing proteins. , By ... molecules present in an organism at a given ...
(Date:4/17/2014)... National University (ANU), have developed a new way ... over the past 5.3 million years., The findings ... ice ages over the past two million years, ... dioxide levels, global temperatures and sea levels., The ... and the National Oceanography Centre (NOC) in the ...
Breaking Biology News(10 mins):Structure of sodium channels different than previously believed 2Rapid and accurate mRNA detection in plant tissues 2Ancient sea-levels give new clues on ice ages 2
... D.C.Carnegie staff scientist Greg Asner has been elected to ... 84 new members and 21 foreign associates from 14 ... achievements in original research." The total number of active ... in 2001 as the Department of Global Ecology,s first ...
... plots in the Northeast and Midwestern United States contain at ... study found. The study across two dozen states from North ... the landscape where invasive plants might take root. "We ... forest inventory had at least one introduced species, but this ...
... for compounds related in composition to the active ingredient in ... published in the Journal of Leukocyte Biology ... (CB2) receptor in white blood cells, specifically macrophages, appear to ... link through which the pharmaceutical properties of cannabis are manifested. ...
Cached Biology News:Carnegie's Greg Asner elected to National Academy of Sciences 2In the Northeast, forests with entirely native flora are not the norm 2Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies 2
...
...
Collected from sexually matured, mixed breed, mixed sex guinea pigs....
Antibody specific for phosphorylattion of histone H3 that occurs during mitosis. Rabbit polyclonal serum. Antigen: Synthetic peptides derived from histone H3, phosphorylated at serines 10 or 28...
Biology Products: